COMMUNIQUÉS West-GlobeNewswire
-
Alira Health Appoints Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador
17/12/2025 -
Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial
17/12/2025 -
Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors
17/12/2025 -
Structure Therapeutics Announces Initiation of Phase 1 Clinical Study of Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
17/12/2025 -
SAB BIO Announces Positive Confirmatory Clinical Results from the Phase 1 Study of SAB-142 in Development for the Treatment of Stage 3 T1D
17/12/2025 -
TadHealth Awarded San Diego County Office of Education Contract; School Districts to Begin CYBHI Billing in January 2026
17/12/2025 -
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
17/12/2025 -
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
17/12/2025 -
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
17/12/2025 -
Alignment Healthcare to Present at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025 -
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025 -
Avalyn to Present at the 44th Annual J.P. Morgan Healthcare Conference
17/12/2025 -
Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference
17/12/2025 -
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
17/12/2025 -
Compass Therapeutics to Participate in the J.P. Morgan 2026 Healthcare Conference
17/12/2025 -
Beyond Air® Signs New International LungFit PH® Distribution Agreements, Most Notably in Germany and Brazil
17/12/2025 -
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
17/12/2025 -
Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy
17/12/2025 -
Kane Biotech Presents New Data at Innovations in Wound Healing Annual Meeting
17/12/2025
Pages